We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Register to chat with like-minded investors on our interactive forums.
The current SBFMW market cap is 3.08M. The company's latest EPS is USD -0.1755 and P/E is -2.51.
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 4.89M | 5.56M | 5.96M | 7.68M | 7.54M |
| Operating Income | -1.83M | -990k | -779k | -1.19M | -1.35M |
| Net Income | -1.7M | -903k | -651k | -1.25M | -1.28M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 21k | 71k | 228k | 4.35M | 24.09M |
| Operating Income | -643k | -577k | -2.44M | -27M | -4.79M |
| Net Income | -1.66M | -2.78M | -12.44M | -26.74M | -4.51M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 26.99M | 28.41M | 27.65M | 27.35M | 31.9M |
| Total Liabilities | 7.56M | 5.3M | 5.69M | 6.14M | 7.08M |
| Total Equity | 19.43M | 23.11M | 21.96M | 21.21M | 24.82M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 98k | 1.05M | 2.2M | 29.24M | 27.35M |
| Total Liabilities | 833k | 2M | 1.99M | 7.62M | 6.14M |
| Total Equity | -735k | -955k | 212k | 21.63M | 21.21M |
| Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -1.85M | -5.63M | -6.09M | -8.78M | -3.19M |
| Investing | -146k | -406k | -387k | -656k | -669k |
| Financing | -538k | 3.52M | 3.46M | 3.43M | 5.4M |
| Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -496k | -657k | -1.83M | -5.25M | -8.78M |
| Investing | -15k | -1,000 | N/A | -14.62M | -656k |
| Financing | 442k | 1.61M | 2.9M | 39.47M | 3.43M |
| Market Cap | 3.08M |
| Price to Earnings Ratio | -2.51 |
| Price to Sales Ratio | 0.47 |
| Price to Cash Ratio | 0.69 |
| Price to Book Ratio | 0.53 |
| Dividend Yield | - |
| Shares Outstanding | 25.68M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | - |
| 52 Week High | - |
| 52 Week Low | - |
| Spread (Intraday) | 0.06 (51.2%) |
| Company Name | Sunshine Biopharma Inc |
| Address |
6500 trans-canada highway 4th floor montreal, quebec H9R 0A5 |
| Website | https://www.sunshinebiopharma.com |
| Industry | coml physical, biologcl resh (8731) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
